The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in more than 90%…
In the thick of his competitive reelection race in Michigan, Republican Rep. Tom Barrett joined Health and Human Services Secretary Robert F. Kennedy Jr. at a sprawling 400-acre apple orchard, farm, and winery. They touted Trump administration efforts to improve the American diet, including the removal of some artificial dyes from processed foods. “We had…
On this “Face the Nation with Margaret Brennan” broadcast, moderated by Margaret Brennan: Neel Kashkari, Minneapolis Fed president and CEO Dr. Mehmet Oz, Centers for Medicare & Medicaid Services administrator Dr. Scott Gottlieb, former FDA commissioner Rep. Byron Donalds, Republican of Florida and candidate for governor Rep. Seth Moulton, Democrat of Massachusetts and…
Drugmaker Moderna’s stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat melanoma, the deadly skin cancer from which more than 8,500 people are expected to die this year. Moderna and Merck, its drug development partner, said the novel treatment prevented melanoma from returning or spreading in a…
A Food and Drug Administration advisory panel voted to broaden access to at least one peptide during a two-day meeting discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes during a surge of interest in the unapproved therapies. Peptides are short strings of amino acids, the building blocks of proteins, linked by…
Imported generic drugs could face tariffs of up to 100% beginning in 2028 under a plan announced Tuesday by President Trump, who said the measure is intended to push manufacturers to move production to the U.S. Health policy experts said they are skeptical the tariffs alone would persuade generic drug manufacturers to relocate production to…
